Actually, another PPAR-γ agonist, azeaolyl PAF, has the ability to increase the expression of frataxin in human neuroblastoma cells, and in primary fibroblasts from FA patients and from healthy controls (Marmolino et al., 2009). The gene discussed is FXN; the disease is Friedreich ataxia.